235 related articles for article (PubMed ID: 19114856)
1. Delayed loss of control of plasma lipopolysaccharide levels after therapy interruption in chronically HIV-1-infected patients.
Papasavvas E; Pistilli M; Reynolds G; Bucki R; Azzoni L; Chehimi J; Janmey PA; DiNubile MJ; Ondercin J; Kostman JR; Mounzer KC; Montaner LJ
AIDS; 2009 Jan; 23(3):369-75. PubMed ID: 19114856
[TBL] [Abstract][Full Text] [Related]
2. Comparative evaluation of microbial translocation products (LPS, sCD14, IgM Endocab) in HIV-1 infected Indian individuals.
Negi N; Singh R; Sharma A; Das BK; Vajpayee M
Microb Pathog; 2017 Oct; 111():331-337. PubMed ID: 28801271
[TBL] [Abstract][Full Text] [Related]
3. Correlation between different methods to measure microbial translocation and its association with immune activation in long-term suppressed HIV-1-infected individuals.
Abad-Fernández M; Vallejo A; Hernández-Novoa B; Díaz L; Gutiérrez C; Madrid N; Muñoz MA; Moreno S
J Acquir Immune Defic Syndr; 2013 Oct; 64(2):149-53. PubMed ID: 24047967
[TBL] [Abstract][Full Text] [Related]
4. Elevated plasma levels of lipopolysaccharide and high mobility group box-1 protein are associated with high viral load in HIV-1 infection: reduction by 2-year antiretroviral therapy.
Trøseid M; Nowak P; Nyström J; Lindkvist A; Abdurahman S; Sönnerborg A
AIDS; 2010 Jul; 24(11):1733-7. PubMed ID: 20502315
[TBL] [Abstract][Full Text] [Related]
5. Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy.
Wallet MA; Rodriguez CA; Yin L; Saporta S; Chinratanapisit S; Hou W; Sleasman JW; Goodenow MM
AIDS; 2010 Jun; 24(9):1281-90. PubMed ID: 20559035
[TBL] [Abstract][Full Text] [Related]
6. Alcohol use predicts elevation in inflammatory marker soluble CD14 in men living with HIV.
Monnig MA; Kahler CW; Cioe PA; Tucker L; Monti PM; Mayer KH; Ramratnam B
AIDS Care; 2016 Nov; 28(11):1434-40. PubMed ID: 27242060
[TBL] [Abstract][Full Text] [Related]
7. Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection.
Dyrhol-Riise AM; Voltersvik P; Olofsson J; Asjö B
AIDS; 1999 Dec; 13(17):2365-76. PubMed ID: 10597778
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 viral replication below 50 copies/ml in patients on antiretroviral therapy is not associated with CD8+ T-cell activation.
Steel A; Cox AE; Shamji MH; John L; Nelson M; Henderson DC; Gotch FM; Gazzard BG; Kelleher P
Antivir Ther; 2007; 12(6):971-5. PubMed ID: 17926652
[TBL] [Abstract][Full Text] [Related]
9. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
[TBL] [Abstract][Full Text] [Related]
10. Increased soluble vascular cell adhesion molecule-1 plasma levels and soluble intercellular adhesion molecule-1 during antiretroviral therapy interruption and retention of elevated soluble vascular cellular adhesion molecule-1 levels following resumption of antiretroviral therapy.
Papasavvas E; Azzoni L; Pistilli M; Hancock A; Reynolds G; Gallo C; Ondercin J; Kostman JR; Mounzer K; Shull J; Montaner LJ
AIDS; 2008 Jun; 22(10):1153-61. PubMed ID: 18525261
[TBL] [Abstract][Full Text] [Related]
11. Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression.
Ruiz L; Martinez-Picado J; Romeu J; Paredes R; Zayat MK; Marfil S; Negredo E; Sirera G; Tural C; Clotet B
AIDS; 2000 Mar; 14(4):397-403. PubMed ID: 10770542
[TBL] [Abstract][Full Text] [Related]
12. Monocyte Based Correlates of Immune Activation and Viremia in HIV-Infected Long-Term Non-Progressors.
Prabhu VM; Singh AK; Padwal V; Nagar V; Patil P; Patel V
Front Immunol; 2019; 10():2849. PubMed ID: 31867010
[No Abstract] [Full Text] [Related]
13. HIV-1 control after transient antiretroviral treatment initiated in primary infection: role of patient characteristics and effect of therapy.
Goujard C; Girault I; Rouzioux C; Lécuroux C; Deveau C; Chaix ML; Jacomet C; Talamali A; Delfraissy JF; Venet A; Meyer L; Sinet M;
Antivir Ther; 2012; 17(6):1001-9. PubMed ID: 22865544
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 low-level viremia affects T cell activation rather than T cell development in school-age children, adolescents, and young adults during antiretroviral therapy.
Han J; Mu W; Zhao H; Hao Y; Song C; Zhou H; Sun X; Li G; Dai G; Zhang Y; Zhang F; Zeng H
Int J Infect Dis; 2020 Feb; 91():210-217. PubMed ID: 31821891
[TBL] [Abstract][Full Text] [Related]
15. Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience.
Gray CM; Schapiro JM; Winters MA; Merigan TC
AIDS Res Hum Retroviruses; 1998 May; 14(7):561-9. PubMed ID: 9591710
[TBL] [Abstract][Full Text] [Related]
16. Increased Tryptophan Catabolism Is Associated With Increased Frequency of CD161+Tc17/MAIT Cells and Lower CD4+ T-Cell Count in HIV-1 Infected Patients on cART After 2 Years of Follow-Up.
Gaardbo JC; Trøsied M; Stiksrud B; Midttun Ø; Ueland PM; Ullum H; Nielsen SD
J Acquir Immune Defic Syndr; 2015 Nov; 70(3):228-35. PubMed ID: 26470032
[TBL] [Abstract][Full Text] [Related]
17. Systemic immune activation and microbial translocation in dual HIV/tuberculosis-infected subjects.
Toossi Z; Funderburg NT; Sirdeshmuk S; Whalen CC; Nanteza MW; Johnson DF; Mayanja-Kizza H; Hirsch CS
J Infect Dis; 2013 Jun; 207(12):1841-9. PubMed ID: 23479321
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM
AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217
[TBL] [Abstract][Full Text] [Related]
19. Immune reconstitution in human immunodeficiency virus type 1-infected children with different virological responses to anti-retroviral therapy.
Anselmi A; Vendrame D; Rampon O; Giaquinto C; Zanchetta M; De Rossi A
Clin Exp Immunol; 2007 Dec; 150(3):442-50. PubMed ID: 17956580
[TBL] [Abstract][Full Text] [Related]
20. Increased microbial translocation in ≤ 180 days old perinatally human immunodeficiency virus-positive infants as compared with human immunodeficiency virus-exposed uninfected infants of similar age.
Papasavvas E; Azzoni L; Foulkes A; Violari A; Cotton MF; Pistilli M; Reynolds G; Yin X; Glencross DK; Stevens WS; McIntyre JA; Montaner LJ
Pediatr Infect Dis J; 2011 Oct; 30(10):877-82. PubMed ID: 21552185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
